IBDEI1XJ ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,30823,1,4,0)
;;=4^T86.10
;;^UTILITY(U,$J,358.3,30823,2)
;;=^5055708
;;^UTILITY(U,$J,358.3,30824,0)
;;=T86.11^^123^1593^6
;;^UTILITY(U,$J,358.3,30824,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30824,1,3,0)
;;=3^Kidney Transplant Rejection
;;^UTILITY(U,$J,358.3,30824,1,4,0)
;;=4^T86.11
;;^UTILITY(U,$J,358.3,30824,2)
;;=^5055709
;;^UTILITY(U,$J,358.3,30825,0)
;;=T86.12^^123^1593^4
;;^UTILITY(U,$J,358.3,30825,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30825,1,3,0)
;;=3^Kidney Transplant Failure
;;^UTILITY(U,$J,358.3,30825,1,4,0)
;;=4^T86.12
;;^UTILITY(U,$J,358.3,30825,2)
;;=^5055710
;;^UTILITY(U,$J,358.3,30826,0)
;;=T86.13^^123^1593^5
;;^UTILITY(U,$J,358.3,30826,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30826,1,3,0)
;;=3^Kidney Transplant Infection
;;^UTILITY(U,$J,358.3,30826,1,4,0)
;;=4^T86.13
;;^UTILITY(U,$J,358.3,30826,2)
;;=^5055711
;;^UTILITY(U,$J,358.3,30827,0)
;;=Z94.0^^123^1593^7
;;^UTILITY(U,$J,358.3,30827,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30827,1,3,0)
;;=3^Kidney Transplant Status
;;^UTILITY(U,$J,358.3,30827,1,4,0)
;;=4^Z94.0
;;^UTILITY(U,$J,358.3,30827,2)
;;=^5063654
;;^UTILITY(U,$J,358.3,30828,0)
;;=Z48.22^^123^1593^1
;;^UTILITY(U,$J,358.3,30828,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30828,1,3,0)
;;=3^Aftercare Following Kidney Transplant
;;^UTILITY(U,$J,358.3,30828,1,4,0)
;;=4^Z48.22
;;^UTILITY(U,$J,358.3,30828,2)
;;=^5063039
;;^UTILITY(U,$J,358.3,30829,0)
;;=Z52.4^^123^1593^2
;;^UTILITY(U,$J,358.3,30829,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30829,1,3,0)
;;=3^Kidney Donor
;;^UTILITY(U,$J,358.3,30829,1,4,0)
;;=4^Z52.4
;;^UTILITY(U,$J,358.3,30829,2)
;;=^5063082
;;^UTILITY(U,$J,358.3,30830,0)
;;=D47.Z1^^123^1593^8
;;^UTILITY(U,$J,358.3,30830,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30830,1,3,0)
;;=3^Post-Transplant Lymphoproliferative Disorder (PTLD)
;;^UTILITY(U,$J,358.3,30830,1,4,0)
;;=4^D47.Z1
;;^UTILITY(U,$J,358.3,30830,2)
;;=^5002261
;;^UTILITY(U,$J,358.3,30831,0)
;;=N18.1^^123^1594^1
;;^UTILITY(U,$J,358.3,30831,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30831,1,3,0)
;;=3^Chr Kidney Disease,Stage 1
;;^UTILITY(U,$J,358.3,30831,1,4,0)
;;=4^N18.1
;;^UTILITY(U,$J,358.3,30831,2)
;;=^5015602
;;^UTILITY(U,$J,358.3,30832,0)
;;=N18.2^^123^1594^2
;;^UTILITY(U,$J,358.3,30832,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30832,1,3,0)
;;=3^Chr Kidney Disease,Stage 2
;;^UTILITY(U,$J,358.3,30832,1,4,0)
;;=4^N18.2
;;^UTILITY(U,$J,358.3,30832,2)
;;=^5015603
;;^UTILITY(U,$J,358.3,30833,0)
;;=N18.3^^123^1594^3
;;^UTILITY(U,$J,358.3,30833,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30833,1,3,0)
;;=3^Chr Kidney Disease,Stage 3
;;^UTILITY(U,$J,358.3,30833,1,4,0)
;;=4^N18.3
;;^UTILITY(U,$J,358.3,30833,2)
;;=^5015604
;;^UTILITY(U,$J,358.3,30834,0)
;;=N18.4^^123^1594^4
;;^UTILITY(U,$J,358.3,30834,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30834,1,3,0)
;;=3^Chr Kidney Disease,Stage 4
;;^UTILITY(U,$J,358.3,30834,1,4,0)
;;=4^N18.4
;;^UTILITY(U,$J,358.3,30834,2)
;;=^5015605
;;^UTILITY(U,$J,358.3,30835,0)
;;=N18.5^^123^1594^5
;;^UTILITY(U,$J,358.3,30835,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30835,1,3,0)
;;=3^Chr Kidney Disease,Stage 5
;;^UTILITY(U,$J,358.3,30835,1,4,0)
;;=4^N18.5
;;^UTILITY(U,$J,358.3,30835,2)
;;=^5015606
;;^UTILITY(U,$J,358.3,30836,0)
;;=N18.9^^123^1594^6
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1XJ 3777 printed Dec 13, 2024@02:17:44 Page 2
IBDEI1XJ ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,30823,1,4,0)
+2 ;;=4^T86.10
+3 ;;^UTILITY(U,$J,358.3,30823,2)
+4 ;;=^5055708
+5 ;;^UTILITY(U,$J,358.3,30824,0)
+6 ;;=T86.11^^123^1593^6
+7 ;;^UTILITY(U,$J,358.3,30824,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,30824,1,3,0)
+10 ;;=3^Kidney Transplant Rejection
+11 ;;^UTILITY(U,$J,358.3,30824,1,4,0)
+12 ;;=4^T86.11
+13 ;;^UTILITY(U,$J,358.3,30824,2)
+14 ;;=^5055709
+15 ;;^UTILITY(U,$J,358.3,30825,0)
+16 ;;=T86.12^^123^1593^4
+17 ;;^UTILITY(U,$J,358.3,30825,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,30825,1,3,0)
+20 ;;=3^Kidney Transplant Failure
+21 ;;^UTILITY(U,$J,358.3,30825,1,4,0)
+22 ;;=4^T86.12
+23 ;;^UTILITY(U,$J,358.3,30825,2)
+24 ;;=^5055710
+25 ;;^UTILITY(U,$J,358.3,30826,0)
+26 ;;=T86.13^^123^1593^5
+27 ;;^UTILITY(U,$J,358.3,30826,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,30826,1,3,0)
+30 ;;=3^Kidney Transplant Infection
+31 ;;^UTILITY(U,$J,358.3,30826,1,4,0)
+32 ;;=4^T86.13
+33 ;;^UTILITY(U,$J,358.3,30826,2)
+34 ;;=^5055711
+35 ;;^UTILITY(U,$J,358.3,30827,0)
+36 ;;=Z94.0^^123^1593^7
+37 ;;^UTILITY(U,$J,358.3,30827,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,30827,1,3,0)
+40 ;;=3^Kidney Transplant Status
+41 ;;^UTILITY(U,$J,358.3,30827,1,4,0)
+42 ;;=4^Z94.0
+43 ;;^UTILITY(U,$J,358.3,30827,2)
+44 ;;=^5063654
+45 ;;^UTILITY(U,$J,358.3,30828,0)
+46 ;;=Z48.22^^123^1593^1
+47 ;;^UTILITY(U,$J,358.3,30828,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,30828,1,3,0)
+50 ;;=3^Aftercare Following Kidney Transplant
+51 ;;^UTILITY(U,$J,358.3,30828,1,4,0)
+52 ;;=4^Z48.22
+53 ;;^UTILITY(U,$J,358.3,30828,2)
+54 ;;=^5063039
+55 ;;^UTILITY(U,$J,358.3,30829,0)
+56 ;;=Z52.4^^123^1593^2
+57 ;;^UTILITY(U,$J,358.3,30829,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,30829,1,3,0)
+60 ;;=3^Kidney Donor
+61 ;;^UTILITY(U,$J,358.3,30829,1,4,0)
+62 ;;=4^Z52.4
+63 ;;^UTILITY(U,$J,358.3,30829,2)
+64 ;;=^5063082
+65 ;;^UTILITY(U,$J,358.3,30830,0)
+66 ;;=D47.Z1^^123^1593^8
+67 ;;^UTILITY(U,$J,358.3,30830,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,30830,1,3,0)
+70 ;;=3^Post-Transplant Lymphoproliferative Disorder (PTLD)
+71 ;;^UTILITY(U,$J,358.3,30830,1,4,0)
+72 ;;=4^D47.Z1
+73 ;;^UTILITY(U,$J,358.3,30830,2)
+74 ;;=^5002261
+75 ;;^UTILITY(U,$J,358.3,30831,0)
+76 ;;=N18.1^^123^1594^1
+77 ;;^UTILITY(U,$J,358.3,30831,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,30831,1,3,0)
+80 ;;=3^Chr Kidney Disease,Stage 1
+81 ;;^UTILITY(U,$J,358.3,30831,1,4,0)
+82 ;;=4^N18.1
+83 ;;^UTILITY(U,$J,358.3,30831,2)
+84 ;;=^5015602
+85 ;;^UTILITY(U,$J,358.3,30832,0)
+86 ;;=N18.2^^123^1594^2
+87 ;;^UTILITY(U,$J,358.3,30832,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,30832,1,3,0)
+90 ;;=3^Chr Kidney Disease,Stage 2
+91 ;;^UTILITY(U,$J,358.3,30832,1,4,0)
+92 ;;=4^N18.2
+93 ;;^UTILITY(U,$J,358.3,30832,2)
+94 ;;=^5015603
+95 ;;^UTILITY(U,$J,358.3,30833,0)
+96 ;;=N18.3^^123^1594^3
+97 ;;^UTILITY(U,$J,358.3,30833,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,30833,1,3,0)
+100 ;;=3^Chr Kidney Disease,Stage 3
+101 ;;^UTILITY(U,$J,358.3,30833,1,4,0)
+102 ;;=4^N18.3
+103 ;;^UTILITY(U,$J,358.3,30833,2)
+104 ;;=^5015604
+105 ;;^UTILITY(U,$J,358.3,30834,0)
+106 ;;=N18.4^^123^1594^4
+107 ;;^UTILITY(U,$J,358.3,30834,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,30834,1,3,0)
+110 ;;=3^Chr Kidney Disease,Stage 4
+111 ;;^UTILITY(U,$J,358.3,30834,1,4,0)
+112 ;;=4^N18.4
+113 ;;^UTILITY(U,$J,358.3,30834,2)
+114 ;;=^5015605
+115 ;;^UTILITY(U,$J,358.3,30835,0)
+116 ;;=N18.5^^123^1594^5
+117 ;;^UTILITY(U,$J,358.3,30835,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,30835,1,3,0)
+120 ;;=3^Chr Kidney Disease,Stage 5
+121 ;;^UTILITY(U,$J,358.3,30835,1,4,0)
+122 ;;=4^N18.5
+123 ;;^UTILITY(U,$J,358.3,30835,2)
+124 ;;=^5015606
+125 ;;^UTILITY(U,$J,358.3,30836,0)
+126 ;;=N18.9^^123^1594^6
